|
PARP-1 (human) (recombinant) (high purity) |
|
|
ALX-201-063-C020 |
|
20 µg |
348.00 USD |
|
 |
|
|
PARP-1 (Catalytic Domain) (human) (recombinant) (His) |
|
|
ALX-201-232-C020 |
|
20 µg |
380.00 USD |
|
|
|
|
PARP-1 (human) (recombinant) (high purity) (His) |
|
|
ALX-201-250-C010 |
|
10 µg |
240.00 USD |
|
|
|
|
PARP-1b (human) (recombinant) (active) (His) |
|
|
ALX-201-253-C020 |
|
20 µg |
240.00 USD |
|
|
|
|
PARP-1 (E988K mutant) (human) (recombinant) (Control) |
|
|
ALX-201-254-C010 |
|
10 µg |
180.00 USD |
|
|
|
|
PARP-1 (BRCT Domain) (human) (recombinant) (His) |
|
|
ALX-201-255-C020 |
|
20 µg |
290.00 USD |
|
|
|
|
PARP-1 (bovine) (~90%) |
|
|
ALX-202-042-C010 |
|
10 µg |
180.00 USD |
|
|
|
|
PARP-1 (bovine) (automodified) Standard |
|
|
ALX-202-044-R100 |
|
100 µl |
70.00 USD |
|
|
|
|
PARP-1 (bovine) (~98%) |
|
|
ALX-202-046-C010 |
|
10 µg |
250.00 USD |
|
|
|
|
PAb to PARP-1 (197-214) |
|
|
ALX-210-219-R100 |
|
100 µl |
240.00 USD |
|
|
|
|
PAb to PARP-1 (215-228) |
|
|
ALX-210-220-R100 |
|
100 µl |
240.00 USD |
|
|
|
|
PAb to PARP-1 |
|
|
ALX-210-221-R100 |
|
100 µl |
240.00 USD |
|
|
|
|
PAb to PARP-1 (509-524) |
|
|
ALX-210-222-R100 |
|
100 µl |
240.00 USD |
|
|
|
|
PAb to PARP-1 |
|
|
ALX-210-302-R100 |
|
100 µl |
235.00 USD |
|
|
|
|
PAb to PARP-1 (BRCT Domain) |
|
|
ALX-210-540-R100 |
|
100 µl |
250.00 USD |
|
|
|
|
PAb to PARP-1 (mouse) |
|
|
ALX-210-619-R100 |
|
100 µl |
260.00 USD |
|
|
|
|
PAb to PARP-1 (1-232) (human) |
|
|
ALX-210-771-1 |
|
1 Vial |
220.00 USD |
|
|
|
|
PAb to PARP-1 (human) |
|
|
ALX-210-895-R100 |
|
100 µl |
260.00 USD |
|
|
|
|
PAb to PARP-1 (human) |
|
|
ALX-210-897-R100 |
|
100 µl |
235.00 USD |
|
|
|
|
MAb to PARP-1 (C2-10) |
|
|
ALX-804-210-R050 |
|
50 µl |
380.00 USD |
|
|
|
